Argenica Therapeutics(ASX: AGN) is developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. Stroke is the leading cause of death and disability worldwide and the economic costs of treatment a...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2019 (5 years) |
Funding status Private |
Company type SME |
CFO & Company Secretary
Head of Clinical Development
Clinical Advisory Committee
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
CFO & Company Secretary | hidden.item | hidden.item | hidden.item | |||
Head of Clinical Development | hidden.item | hidden.item | hidden.item | |||
Clinical Advisory Committee | hidden.item | hidden.item | hidden.item |